PROCEEDINGS VOLUME 1203
OE/LASE '90 | 14-14 JANUARY 1990
Photodynamic Therapy: Mechanisms II
OE/LASE '90
14-14 January 1990
Los Angeles, CA, United States
Tumor Detection/Tissue Optical Properties/Dosimetry
Proc. SPIE 1203, Optical characteristics of intraocular tumors in the visible and near infrared, 0000 (1 July 1990); doi: 10.1117/12.17645
Proc. SPIE 1203, Diagnosis of tumors by fluorescence: quantification of photosensitizer concentration, 0000 (1 July 1990); doi: 10.1117/12.17646
Proc. SPIE 1203, Factors of importance in the generation of singlet oxygen during photodynamic treatment of tumors, 0000 (1 July 1990); doi: 10.1117/12.17647
Proc. SPIE 1203, In-vivo photodynamic therapy dosimeter, 0000 (1 July 1990); doi: 10.1117/12.17648
Proc. SPIE 1203, Photodetection of early cancer by laser-induced fluorescence of a tumor-selective dye: apparatus design and realization, 0000 (1 July 1990); doi: 10.1117/12.17649
Proc. SPIE 1203, Treatment planning for photodynamic therapy: semi-empirical model and clinical trials on head and neck carcinoma, 0000 (1 July 1990); doi: 10.1117/12.17651
Proc. SPIE 1203, Applications of time-resolved light scattering measurements to photodynamic therapy dosimetry, 0000 (1 July 1990); doi: 10.1117/12.17652
Proc. SPIE 1203, Laser-induced fluorescence in medical diagnostics, 0000 (1 July 1990); doi: 10.1117/12.17653
Proc. SPIE 1203, Spectroscopic and quantitative measurements of singlet oxygen molecules generated in laser-excited photosensitive dyes, 0000 (1 July 1990); doi: 10.1117/12.17654
Tissue Targeting of Photosensitizers
Proc. SPIE 1203, Use of liposomes, emulsions, or inclusion complexes may potentiate in-vivo effects of SnET2, 0000 (1 July 1990); doi: 10.1117/12.17655
Proc. SPIE 1203, Experience with the liposomal delivery of the photosensitizer isoBoSiNc, 0000 (1 July 1990); doi: 10.1117/12.17656
Proc. SPIE 1203, Cellular response of ovarian carcinoma cells to antibody-photosensitizer-mediated injury, 0000 (1 July 1990); doi: 10.1117/12.17657
Proc. SPIE 1203, Targetable N-(2-hydroxypropyl)methacrylamide copolymer-chlorin e6 conjugates, 0000 (1 July 1990); doi: 10.1117/12.17658
Proc. SPIE 1203, Immunological effects of photodynamic therapy, 0000 (1 July 1990); doi: 10.1117/12.17659
Tissue Effects/New Photosensitizers
Proc. SPIE 1203, Kinetics of tumor necrosis factor production by photodynamic-therapy-activated macrophages, 0000 (1 July 1990); doi: 10.1117/12.17660
Proc. SPIE 1203, Studies on the mechanism of photodynamic-therapy-induced tumor destruction, 0000 (1 July 1990); doi: 10.1117/12.17661
Proc. SPIE 1203, Porphyrin photosensitivity in cell lines expressing a heat-resistant phenotype, 0000 (1 July 1990); doi: 10.1117/12.17663
Proc. SPIE 1203, Canine treatment with SnET2 for photodynamic therapy, 0000 (1 July 1990); doi: 10.1117/12.17665
Proc. SPIE 1203, Novel benzophenothiazinium photosensitizers: preliminary in-vivo results, 0000 (1 July 1990); doi: 10.1117/12.17666
Proc. SPIE 1203, Bacteriochlorophyll-a as photosensitizer for photodynamic treatment of transplantable murine tumors, 0000 (1 July 1990); doi: 10.1117/12.17667
New Photosensitizers
Proc. SPIE 1203, Synthesis and characterization of naphthalocyanines and phthalocyanines of use in sensitizer studies, 0000 (1 July 1990); doi: 10.1117/12.17668
Proc. SPIE 1203, Photodynamic inactivation of enveloped viruses using sapphyrin, a 22 pi-electron expanded porphyrin: possible approaches to prophylactic blood purification protocols, 0000 (1 July 1990); doi: 10.1117/12.17669
Proc. SPIE 1203, Effect of axial ligands and macroring substituants on the photosensitizing properties of phthalo- and naphthalocyanines, 0000 (1 July 1990); doi: 10.1117/12.17670
Proc. SPIE 1203, Pentamethylpyrromethene boron difluoride complexes in human ovarian cancer photodynamic therapy, 0000 (1 July 1990); doi: 10.1117/12.17671
Proc. SPIE 1203, Comparative studies of selected porphyrin photosensitizers, 0000 (1 July 1990); doi: 10.1117/12.17672
Proc. SPIE 1203, Synthetic approaches to long-wavelength-absorbing photosensitizers: porphyrinone and derivatives, 0000 (1 July 1990); doi: 10.1117/12.17673
Proc. SPIE 1203, Uptake, retention, and phototoxicity of cationic phenoxazines photosensitizers in tumor cells in culture, 0000 (1 July 1990); doi: 10.1117/12.17676
Proc. SPIE 1203, Potential new photosensitizers for photodynamic therapy, 0000 (1 July 1990); doi: 10.1117/12.17677
Tissue Targeting of Photosensitizers
Proc. SPIE 1203, Fluorescent-tip optical fiber probe for quantitative light dosimetry in light scattering media and in tissue, 0000 (1 July 1990); doi: 10.1117/12.17678
Tissue Effects/New Photosensitizers
Proc. SPIE 1203, Enhanced toxicity in chemotherapeutic drug Epirubicin-treated human bladder cancer cells after pulsed versus continuous irradiation, 0000 (1 July 1990); doi: 10.1117/12.17679
Back to Top